The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (16 analysts) rates it buy, with a mean price target of $82.
Freshpet, Inc. FRPT
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Freshpet, Inc., together with its subsidiaries, manufactures, distributes, and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe.
read at $56.64
Freshpet, Inc. holds its Accumulation at $56.64.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 51 days |
| Price | $56.64 |
| Valuation | 14.87 trailing · 31.41 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.61 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 13.10% |
| Profit margin | 17.63% |
| Debt to equity | 39.15 |
| Analyst consensus | Buy · 16 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Premium pet food priced beyond its value
Picture a dog owner paying top dollar for fresh meals that feel like human-grade cooking. Freshpet delivers solid 13% revenue growth and 18% profit margins with 17% returns on equity, yet the shares trade at 31.4 times forward earnings, just above our fair value with a negative margin of safety. The market already prices in the growth story, leaving no clear entry point despite the ethical screen pass.
We pass because the numbers do not stack up for new capital. Consensus targets sit near 80 from sixteen analysts, but that optimism sits against a valuation that already bakes in continued expansion without room for error. Unknown competitive moat adds another layer of uncertainty in a category where big food groups can copy recipes quickly.
High multiples on modest growth carry real downside if consumer spending on premium pet products slows. Defensive label offers some cushion, yet paying above fair value still leaves investors exposed to any miss on the growth path. Analysis, not advice.
| Forward P/E | 31.4x expensive even after accounting for its growth |
| Trailing P/E | 14.9x reasonably valued |
| Revenue growth | 13.1% steady growth |
| Profit margin | 17.6% healthy profit margins |
| Return on equity | 17.3% a solid return on shareholder capital |
| Debt to equity | 0.39 minimal debt — a conservative balance sheet |
| Current ratio | 6.18 comfortably covers its short-term bills |
| Beta | 1.61 much more volatile than the market |
| Market cap | $2.8B |
| Employees | 1,288 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in FRPT's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
FRPT trades on Nasdaq. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 36%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (16 analysts) rates it buy, with a mean price target of $82.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $49.64 | +2.3% | · | $1,023 | +2.3% |
| 2 months | $64.80 | -21.6% | · | $784 | -21.6% |
| 3 months | $78.04 | -34.9% | · | $651 | -34.9% |
| 6 months | $62.89 | -19.2% | · | $808 | -19.2% |
| 1 year | $78.89 | -35.6% | · | $644 | -35.6% |
| 2 years | $129.93 | -60.9% | · | $391 | -60.9% |
| 3 years | $66.07 | -23.1% | · | $769 | -23.1% |
| 5 years | $167.74 | -69.7% | · | $303 | -69.7% |
Historical returns from market close data. Past performance does not guarantee future results.